Get started
Author

Mohamed A. Elkady

Observed names: Elkady, Mohamed A., Mohamed A Elkady, Mohamed Elkady, Mohamed A. Elkady
Observed institutions: Sinai University, Al-Azhar University, Al-Azhar University, Al Azhar University, Agricultural Research Center, Menoufia University
ORCID: 0000-0002-6475-6937
Observed ORCID: 0000-0002-6475-6937
OpenAlex ID: A5021759842
A review of the biological role of miRNAs in prostate cancer suppression and progression
2021 · Ahmed S. Doghish, Ahmed Ismail, et al. · International Journal of Biological Macromolecules · 109
MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8
2021 · Mohamed A. Elkady, Ahmed S. Doghish, et al. · Saudi Journal of Biological Sciences · 88
PDF
miRNAs as cornerstones in adipogenesis and obesity
2023 · Samy Y. Elkhawaga, Ahmed Ismail, et al. · Life Sciences · 79
Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways
2023 · Ahmed S. Doghish, Hesham A. El-Mahdy, et al. · Pathology - Research and Practice · 60
A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance
2023 · Ahmed S. Doghish, Maghawry Hegazy, et al. · Pathology - Research and Practice · 59
The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay
2023 · Maghawry Hegazy, Mohamed A. Elkady, et al. · Pathology - Research and Practice · 56
Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats
2023 · Shady Allam, Elsayed G.E. Elsakka, et al. · Life Sciences · 50
Matrix metalloproteinase (MMP)-2 -1306 C > T gene polymorphism affects circulating levels of MMP-2 in Egyptian asthmatic patients
2016 · Mohamed A. Elkady, Gamil M. Abd-Allah, et al. · Gene Reports · 49
miRNAs orchestration of gallbladder cancer – Particular emphasis on diagnosis, progression and drug resistance
2023 · Reem K. Shahin, Mohamed A. Elkady, et al. · Pathology - Research and Practice · 47
Decoding the role of miRNAs in multiple myeloma pathogenesis: A focus on signaling pathways
2023 · Amr Mohamed Yehia, Elsayed G.E. Elsakka, et al. · Pathology - Research and Practice · 39
miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma
2023 · Mohamed A. Elkady, Amr Mohamed Yehia, et al. · Pathology - Research and Practice · 33
New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations
2023 · Hazem A Mahdy, Hazem Elkady, et al. · Future Medicinal Chemistry · 31
Design, synthesis, in vitro, and in silico studies of new thiadiazol derivatives as promising VEGFR-2 inhibitors and apoptosis inducers
2024 · Hazem A. Mahdy, Hazem Elkady, et al. · Journal of Molecular Structure · 27
Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: in silico and in vitro evaluations
2023 · Mohammed A. Dahab, Hazem A. Mahdy, et al. · Journal of Biomolecular Structure and Dynamics · 24
Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression
2023 · Aml Ghanem, Mohamed A. Ali, et al. · Pathology - Research and Practice · 22
From diagnosis to resistance: a symphony of miRNAs in pheochromocytoma progression and treatment response
2023 · Elsayed G. E. Elsakka, Ahmed Elshafei, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 19
New vatalanib analogs: Design, synthesis, in silico study and biological evaluation for anticancer activity
2024 · Abdallah E. Abdallah, Hazem Elkady, et al. · Journal of Molecular Structure · 17
Biological and computational assessment of new synthesized nicotinamides as potential immunomodulatory VEGFR-2 inhibitors
2024 · Reda G. Yousef, Alaa Elwan, et al. · Journal of Molecular Structure · 17
Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2
2023 · Ibrahim H. Eissa, Reda G. Yousef, et al. · Saudi Pharmaceutical Journal · 16
Possible role of miRNAs in pheochromocytoma pathology - Signaling pathways interaction
2023 · Samy Y. Elkhawaga, Ahmed Elshafei, et al. · Pathology - Research and Practice · 14
The role of matrix metalloproteinase-2 and miR-196a2 in bronchial asthma pathogenesis and diagnosis
2024 · Osama A. Mohammed, Ahmed S. Doghish, et al. · Heliyon · 8
Phylotypic Profiling, Distribution of Pathogenicity Island Markers, and Antimicrobial Susceptibility of Escherichia coli Isolated from Retail Chicken Meat and Humans
2022 · Asmaa Sadat, Hazem Ramadan, et al. · Antibiotics · 8
PDF
Design, synthesis, and in silico study of VEGFR-2 and HDAC dual acting quinazoline based molecules for anticancer evaluation
2026 · Abdallah E. Abdallah, Esmail M. El-Fakharany, et al. · Bioorganic Chemistry · 7
Development of new thiadiazole-based compounds targeting VEGFR-2: In vitro anticancer evaluation, mechanistic investigations, and in silico studies
2025 · Bshra A. Alsfouk, Walid E. Elgammal, et al. · Journal of Molecular Structure · 6
Clinical significance of vit D and AMH and its correlation with polycystic ovarian parameters in obese and non-obese Egyptian women
2023 · Maghawry Hegazy, Hesham A. El-Mahdy, et al. · Pathology - Research and Practice · 6
Works count: 34
Citation count: 904
H-index: 17
I10-index: 20
Year
Topic
Type